← Back to Clinical Trials
Recruiting NCT07901985

NCT07901985 A Rehabilitation Data Collection Study in Patients With Spinal Cord Injury

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07901985
Status Recruiting
Phase —
Sponsor Seoul National University Hospital
Condition Spinal Cord Injuries (SCI)
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2024-07-07
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2024-07-07 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to build a rehabilitation registry for people with spinal cord injury (SCI) in Korea and to create foundational data for predicting patients' long-term function. The main question it aims to answer is: \- Can a person's long-term level of disability and functional status after SCI be predicted by collecting medical and socioeconomic information together? Participants receiving inpatient rehabilitation after a spinal cord injury will: * Complete a first (baseline) survey and standard assessments of daily functioning, walking ability, quality of life, and disability at the time of admission * Complete the same assessments again about 6 months and 12 months after discharge * Provide information on their health, use of medical services, employment, income, and social participation during follow-up

Eligibility Criteria

Inclusion Criteria: \[Phase 1(baseline)\] * Patients admitted with spinal cord injury to the Department of Rehabilitation Medicine at the National Traffic Injury Rehabilitation Hospital * Patients able to understand and respond to the study questionnaire without difficulty \[Phases 2 and 3 (follow-up)\] * Patients who participated in the survey during Phase 1 (i.e., those who had been admitted with spinal cord injury to the Department of Rehabilitation Medicine at the National Traffic Injury Rehabilitation Hospital) * Patients who provided consent at the time of the Phase 1 survey and indicated their willingness to take part in the follow-up surveys at approximately 6 months post-discharge (Phase 2) and approximately 12 months post-discharge (Phase 3) Exclusion Criteria: * Patients with a disability that makes participation difficult during administration of the survey * Participants otherwise judged by the investigator to be unsuitable for the study * Patients who participated in the Phase 1 survey but did not consent to the follow-up surveys in Phases 2 and 3

Frequently Asked Questions

Who can join the NCT07901985 clinical trial?

This trial is open to participants of all sexes, studying Spinal Cord Injuries (SCI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07901985 currently recruiting?

Yes, NCT07901985 is actively recruiting participants. Visit ClinicalTrials.gov or contact Seoul National University Hospital to inquire about joining.

Where is the NCT07901985 trial being conducted?

This trial is being conducted at Yangpyeong, South Korea.

Who is sponsoring the NCT07901985 clinical trial?

NCT07901985 is sponsored by Seoul National University Hospital. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology